No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2535238 |
chr6:29645038-29645039 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs563829445 |
chr6:29645039-29645040 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs371727322 |
chr6:29645073-29645074 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs552472247 |
chr6:29645075-29645076 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs2747421 |
chr6:29645118-29645119 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
6 |
rs550545958 |
chr6:29645148-29645149 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs552950660 |
chr6:29645167-29645168 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs3823312 |
chr6:29645236-29645237 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs369920154 |
chr6:29645244-29645245 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs548820083 |
chr6:29645275-29645276 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs571009774 |
chr6:29645281-29645282 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs191728813 |
chr6:29645299-29645300 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs207466840 |
chr6:29645315-29645316 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs373875556 |
chr6:29645372-29645373 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs554252275 |
chr6:29645452-29645453 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs570944653 |
chr6:29645453-29645454 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs182403617 |
chr6:29645507-29645508 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs116211033 |
chr6:29645532-29645533 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
19 |
rs71550149 |
chr6:29645545-29645546 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs374649115 |
chr6:29645546-29645547 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs75834742 |
chr6:29645549-29645550 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs61380265 |
chr6:29645567-29645568 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs576153454 |
chr6:29645568-29645569 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs35798759 |
chr6:29645574-29645575 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs387603 |
chr6:29645578-29645579 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs3129063 |
chr6:29645613-29645614 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
27 |
rs572047826 |
chr6:29645630-29645631 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs387642 |
chr6:29645634-29645635 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs116414636 |
chr6:29645663-29645664 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs151101933 |
chr6:29645676-29645677 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs372259171 |
chr6:29645692-29645693 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs4391284 |
chr6:29645726-29645727 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs387640 |
chr6:29645770-29645771 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs4085264 |
chr6:29645885-29645886 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs3129062 |
chr6:29645937-29645938 |
Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs568762529 |
chr6:29645938-29645939 |
Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs141981685 |
chr6:29645944-29645945 |
Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs3117288 |
chr6:29645958-29645959 |
Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs570833161 |
chr6:29645968-29645969 |
Enhancers Weak transcription
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs4085262 |
chr6:29645989-29645990 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs145798158 |
chr6:29646015-29646016 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs573473774 |
chr6:29646124-29646125 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs570056640 |
chr6:29646136-29646137 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs396660 |
chr6:29646165-29646166 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs3906306 |
chr6:29646201-29646202 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs571986180 |
chr6:29646204-29646205 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs540899358 |
chr6:29646253-29646254 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs557645152 |
chr6:29646265-29646266 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs577522961 |
chr6:29646303-29646304 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs544313073 |
chr6:29646426-29646427 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|